The Hulot Laboratory seeks to identify novel predictors of response/toxicity to drugs thus allowing for a greater degree of personalized medicine than is currently available. Read More
Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
November 19, 2013 - Cardiovascular Research Center at Mount Sinai report promising long-term follow-up results for its single dose AAV1/SERCA2a gene therapy in advanced heart failure patients.
A Best Manuscript Award Goes to the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai
November 17, 2013 - Editors of Circulation Research recognize Mount Sinai Heart researchers at AHA Scientific Sessions 2013 for their work to repair and reverse heart attack damage.
Blake A. Adair
Icahn School of Medicine
Cardiovascular Research Center
One Gustave L. Levy Place, Box 1030
New York, NY 10029